Johnson & Johnson's Winning Profits

Before you go, we thought you'd like these...
Before you go close icon

The following video is from Tuesday's edition of Market Foolery, in which host Chris Hill and Motley Fool analysts Matt Argersinger and Jason Moser take a deep dive into today's best investing news.

Shares of Johnson & Johnson got a small boost after the company beat expectations on Q3 profits, in part because of a strong performance from the company's drug division. In this segment, Matt and Jason look at this Dow mega blue chip, and tell investors whether the company is a buy today.

Looking for great dividends?
If you're looking for some long-term investing ideas, you're invited to check out The Motley Fool's brand-new special report, "The 3 Dow Stocks Dividend Investors Need." It's absolutely free, so simply click here now and get your copy today.

The article Johnson & Johnson's Winning Profits originally appeared on

Chris Hill owns shares of Johnson & Johnson. Jason Moser and Matthew Argersinger have no position in any stocks mentioned. The Motley Fool recommends and owns shares of Johnson & Johnson and National Oilwell Varco. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

People are Reading